Skip to main content
Figure 3 | Breast Cancer Research

Figure 3

From: Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments

Figure 3

The discriminatory power of CTX markers and CTX ratios to identify breast cancer-induced bone metastases. Open circles, individual Z scores for hypercalcemic patients with bone metastases (HC+) and normocalcemic patients with bone metastases (NC+). Z scores are calculated using the mean and standard deviation of normocalcemic breast cancer controls without bone metastases. αD = D-aspartyl peptide; αL = L-aspartyl peptide; βL = L-isoaspartyl peptide; CTX, crosslinked C-telopeptide of type I collagen.

Back to article page